The Plastic Surgery Foundation
Log In Donate Now

The PSF President's Page: June 2018

As we enter the summer season, ASPS and The PSF are launching several key initiatives, including:

  1. The Advocacy Summit, to be held in Washington, D.C. June 26-28. This is an event relevant to each of us, and will provide an opportunity to network with leaders from local, state and regional plastic surgery societies. United States Senator Rand Paul, MD, will give the Keynote Congressional Address and discuss emerging issues in health care as well as his efforts to impact federal policy under the Trump Administration. Other highlights include a lecture by political analyst and columnist Charlie Cook, a panel on out-of-network legislation and the impact it has on state laws and physicians, as well as meetings with lawmakers from your home states.
  2. Off-Cycle MTF Biologics/PSF Research Grant, due July 2. Grant applications for up to $100,000 are open to investigators studying allograft tissue transplantation either in clinical or basic science research. Examples of clinical technologies of interest include the use of allograft biologics in breast and soft tissue reconstruction, fat transplantation, tissue engineering and bioprinting.
  3. Open call for abstracts for two international meetings to be held in conjunction with Plastic Surgery The Meeting 2018 in Chicago. These meetings will feature new opportunities for international participation through ASPS/The PSF.
    • International Society of Plastic & Regenerative Surgeons (ISPRES) to be held Sept. 30 to Oct. 1. The abstract deadline is June 15. Submit abstracts here. Registrants of PSTM can add-on attendance at the ISPRES meeting for only $200. The option to add this ticket is available as part of the overall PSTM registration process.
    • World Society of Simulation Surgery to be held Sept. 30. The abstract deadline is Aug. 15 and you can submit abstracts here. Access to the WSSS annual meeting is included in the registration fee for PSTM18.
  4. The PSF Presents: Sunday Night Live with Dana Carvey, a fundraiser to be held Sunday Sept. 30 at Plastic Surgery The Meeting. This will be a fun-filled evening with an internationally recognized comedian and we invite all of you to attend. Those of you who sponsor a table of 10 will have the opportunity to participate in a personal meet-and-greet with Dana Carvey.

This month we will highlight two committees critical to the mission of The PSF in developing and executing registries of relevance to our membership: The Clinical Registries Steering Committee, chaired by Bob Murphy, MD, and the TOPS Steering Committee, chaired by Bruce Mast, MD. Both provide updates on their work below.


Arun Gosain, MD

This month we will highlight two committees critical to the mission of The PSF in developing and executing registries of relevance to our membership: The Clinical Registries Steering Committee, chaired by Bob Murphy, MD, and the TOPS Steering Committee, chaired by Bruce Mast, MD. Both provide updates on their work below.

Clinical Registries Steering Committee Update

The Plastic Surgery Registries Network (PSRN) looks forward to tremendous growth in the year ahead with the launch of the National Breast Implant Registry (NBIR). By providing the infrastructure for breast-implant device tracking, the NBIR will bring in a whole new group of users to the registry program. We are looking to increase the registry program's global impact as the GRAFT registry expands to Canada and Brazil this month. As we continue to improve both the registry performance and the ease of use for the program, we continue to focus on EMR integration for the TOPS and QCDR registries. This functionality is available now, with more than 20 sites going live this month. The committee will also be working to formalize the infrastructure of PSRN-ONE to reduce duplicate data entry across our registries and we anticipate this will be live by June 2019.

Our committee is also pursuing opportunities for members to get more out of their registry participation, such as offering greater recognition for registry participation, Patient-Reported Outcomes tools and enhanced benchmarking reports, as well as the return of offering Category 1 CME by the end of 2018. We are working with the Essentials of Leadership program to examine the challenges that our academic institutions face in registry participation and trying to break down these barriers. Finally, we plan to focus on greater use of our registry data for both analysis and to promote its availability for purchase for our members. We look forward to issuing the first PSRN Annual Report for 2018 in early 2019.

>-Robert Murphy, Jr., MD, Chair

Tracking Operations & Outcomes for Plastic Surgeons (TOPS) Steering Committee Update

The TOPS registry contains nearly 950,000 patient entries and more than 1.6 million procedures from ASPS members. The input of data is truly representative of the U.S. plastic surgery community with regard to practice type (solo, group, academic, etc.). The registry transitioned to the PSRN portal in January 2017, and the new portal has proven to be more user-friendly and easier for data input.

The committee continues to review and provide improvements to data fields captured in the registry, including adding new fields such as "Blood Transfusion Occurrences" and "Length of Stay (Admission Date, Discharge Date)," as well as enhancing data captured for 'Graft/Flap loss' and 'Seroma/Hematoma' complications. A major goal for the steering committee is to determine what types of reports or analysis could be pulled from TOPS monthly, yearly and beyond that could prove useful for the individual plastic surgeon's practice evaluation and/or credentialing – but also to the entire specialty.

The committee also has restructured TOPS Data Access Request process to provide better access to members looking to use TOPS data for their research projects. The committee continues to explore opportunities that go beyond collecting only broad data, including adding more procedure-specific modules to TOPS and to collect more specific data to help plastic surgeons answer specific clinical questions. Development of a Cleft Palate Module with ASMS, for example, is scheduled to be completed later this summer. The committee will explore opportunities to validate outcomes data contained in TOPS with other national databases, including NSQIP. Furthermore, the committee along with the Quality and Performance Management committee continues to expand use of TOPS as a qualified clinical data registry for CMS reporting, as well as ways of integrating TOPS with electronic health records to ease data input.

-Bruce Mast, MD, Chair